Soligenix Announces Recent Accomplishments And Second Quarter 2017 Financial Results
News Channel,
SOURCE Soligenix, Inc. PRINCETON, N.J. Christopher J. Schaber Dr. Schaber continued, "We also continue to actively enroll…
SOURCE Soligenix, Inc. PRINCETON, N.J. Christopher J. Schaber Dr. Schaber continued, "We also continue to actively enroll…
PRINCETON, N.J., Aug. 11, 2017 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX ) (Soligenix or the Company), a late-stage…
PR Newswire PRINCETON, N.J., Aug. 11, 2017 PRINCETON, N.J., Aug. 11, 2017 /PRNewswire/ -- Soligenix, Inc.
PRINCETON, N.J., Aug. 11, 2017 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Aug. 11, 2017 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: ) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Aug. 11, 2017 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX ) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Aug. 11, 2017 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
Information contained on this page is provided by an independent third-party content provider.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
Information contained on this page is provided by an independent third-party content provider.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
SOURCE Soligenix, Inc. "DOM-INNATE" study opens patient enrollment PRINCETON, N.J.
"DOM-INNATE" study opens patient enrollment PRINCETON, N.J., July 27, 2017 /PRNewswire/ -- Soligenix, Inc.
PR Newswire PRINCETON, N.J., July 27, 2017 PRINCETON, N.J., July 27, 2017 /PRNewswire/ -- Soligenix, Inc.
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: ) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
PRINCETON, N.J. Soligenix has been working with leading oncology centers, a number of which participated in the Phase 2 study…
PRINCETON, N.J., July 27, 2017 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
Information contained on this page is provided by an independent third-party content provider.
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…
SOURCE Soligenix, Inc. PRINCETON, N.J. Details of the Oral Presentation: Modulation of Innate Immunity in the Treatment of…